Dual Target CAR-T Cells in B-cell Acute Lymphoblastic Leukemia

Clinical trial NCT04723901 · UNKNOWN

Trial details

NCT number: NCT04723901
Sponsor: Shenzhen University General Hospital
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Dual-target CAR-T Cells B ALL Relapse Refractory B Acute Lymphoblastic Leukemia

Start date: 2020-10-20
Primary completion: 2022-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.